Neogen Chemicals' Q4 FY 2025-26 Quarterly Results

Result Summary

• Neogen Chemicals Ltd reported a 11.4% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Mar (Q4 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 21.7%.
• Its expenses for the quarter were up by 7.0% QoQ and 24.8% YoY.
• The net profit increased 208.7% QoQ and increased 372.6% YoY.
• The earnings per share (EPS) of Neogen Chemicals Ltd stood at 4.32 during Q4 FY 2025-26.

Financial Statments for Q4 FY 2025-26

---

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Neogen Chemicals Ltd is a prominent player in the chemical industry, primarily engaged in the manufacturing of bromine-based and lithium-based compounds. The company serves a variety of industries, including pharmaceuticals, agrochemicals, and specialty chemicals. Neogen Chemicals is known for its extensive portfolio of advanced intermediates and specialty chemicals, which are essential for a range of industrial applications. While specific recent major developments in the company are not detailed in the provided data, Neogen Chemicals continues to focus on expanding its production capabilities and enhancing its product offerings to meet the growing demand in its served markets.

Revenue

During Q4FY26, Neogen Chemicals Ltd reported a total income of ₹247.54 crores, marking an 11.4% increase from the previous quarter (Q3FY26) where the company recorded ₹222.11 crores. Compared to the same quarter in the previous year (Q4FY25), total income saw a notable rise of 21.7%, from ₹203.41 crores. This growth in revenue reflects the company's ability to enhance its sales performance over both quarterly and yearly periods, highlighting a strong revenue stream. The consistent increase in total income over these periods underscores the company's successful revenue-generating strategies.

Profitability

Neogen Chemicals Ltd's profitability has shown significant improvements over the analyzed periods. In Q4FY26, the company recorded a profit before tax of ₹15.82 crores, a substantial increase of 180.0% from ₹5.65 crores in Q3FY26. Year-over-year, this represents a remarkable 335.8% growth from Q4FY25's profit before tax of ₹3.63 crores. The profit after tax for Q4FY26 was ₹11.39 crores, which is a 208.7% increase from the previous quarter and 372.6% higher than the same quarter last year. The earnings per share also saw a significant rise to ₹4.32 in Q4FY26 from ₹1.40 in Q3FY26 and ₹0.91 in Q4FY25, reflecting a 208.6% and 374.7% increase, respectively. These figures demonstrate robust improvements in profitability on both a quarterly and yearly basis, showcasing enhanced financial performance.

Operating Metrics

The financial data reveals that Neogen Chemicals Ltd incurred total expenses of ₹231.72 crores in Q4FY26, up from ₹216.46 crores in Q3FY26, representing a 7.0% increase. When compared to Q4FY25, total expenses increased by 24.8% from ₹185.70 crores. The tax expense for Q4FY26 was ₹4.46 crores, compared to ₹2.07 crores in Q3FY26 and ₹1.27 crores in Q4FY25, indicating a rise of 115.5% quarter-over-quarter and 251.2% year-over-year. These operating metrics reflect the company's cost structure and tax obligations over the analyzed periods, providing insight into its operational dynamics and fiscal responsibilities.